Inari Medical Inc Receivables Turnover Ratio (NARI), from the third quarter 2024 to the third quarter 2023 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Inari Medical Inc   (NASDAQ: NARI)
 

Inari Medical Inc Accounts Receivables Turnover Ratio from the third quarter 2024 to the third quarter 2023

Quarterly Results, Trends, Rankings, Statistics


Accounts Receivable turnover ratio remained unchanged during the third quarter 2024, compared to the previous quarter at 7.27 pointing to a challenging and on top of that deteriorating business climate for the Medical Equipment & Supplies industry. Average collection period, for Inari Medical Inc 's accounts receivable remained unchanged at 50 days, in the Sep 30 2024 quarter.

If we take a look into Healthcare sector 228 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1960, from overall ranking in the second quarter 2024 at 1976.

What is Receivable Turnover Ratio?
What is Inari Medical Inc Selling?


What is Receivable Turnover Ratio?





NARI Receivables Turnover Ratio (Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
Y / Y Receivable Change 21.28 % 29.31 % 41.1 % 19.63 % 28.74 %
Y / Y Revenue Change 21.17 % 21.7 % 22.5 % 22.95 % 30.86 %
Receivable Turnover Ratio (TTM) 7.27 7.27 7.39 7.64 7.59
NARI's Total Ranking # 1960 # 1976 # 1969 # 2156 # 1926
Accounts Receivable average collection period days 50 50 49 48 48
Seq. Receivable Change 3.4 % 3.83 % 12.13 % 0.75 % 10.24 %
Seq. Revenue Change 5.33 % 1.78 % 7.39 % 5.25 % 5.78 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 82
Healthcare Sector # 229
Overall Market # 1960

Receivable Turnover Ratio Statistics
High Average Low
7.77 7.44 6.6
(Mar 31 2022)   (Jun 30 2020)






Financial Statements
Inari Medical Inc 's Accounts Receivable $ 84 Millions Visit NARI's Balance sheet
Inari Medical Inc 's Sales TTM $ 572 Millions Visit NARI's Income Statement
Sources of NARI's Revenues Visit NARI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NARI's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NARI's Growth Rates NARI's Roa NARI's Inventory Turnover Ratio NARI's Dividend Comparisons
NARI's Profitability Ratios NARI's Roi NARI's Asset Turnover Ratio NARI's Dividend Growth
NARI's Valuation Ratios NARI's Roe NARI's Financial Strength Ratios NARI's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2024 Receivable at quarter ending Sep 30 2024
Kiniksa Pharmaceuticals International Plc  18.60 $ 384.098  Millions$ 20.650  Millions
Pulmatrix Inc   18.56 $ 10.005  Millions$ 0.539  Millions
Milestone Scientific Inc   18.54 $ 8.862  Millions$ 0.478  Millions
Hookipa Pharma inc   17.97 $ 49.999  Millions$ 2.782  Millions
Vireo Growth Inc.  17.70 $ 98.534  Millions$ 5.568  Millions
Macrogenics Inc   17.38 $ 141.329  Millions$ 8.132  Millions
Silence Therapeutics Plc  17.27 $ 43.010  Millions$ 2.490  Millions
Innovage Holding Corp   17.01 $ 786.512  Millions$ 46.249  Millions
Talkspace Inc   16.98 $ 179.853  Millions$ 10.591  Millions
Scorpius Holdings inc   16.51 $ 10.044  Millions$ 0.608  Millions
Arvinas Inc   16.48 $ 161.100  Millions$ 9.775  Millions
Stablecoin Development Corporation  16.33 $ 11.199  Millions$ 0.686  Millions
Bgm Group Ltd  16.31 $ 24.115  Millions$ 1.478  Millions
Nexalin Technology Inc   16.24 $ 0.162  Millions$ 0.010  Millions
Precipio inc   16.07 $ 17.411  Millions$ 1.084  Millions
Sangamo Therapeutics Inc   15.97 $ 52.291  Millions$ 3.274  Millions
Icu Medical Inc  14.80 $ 2,340.754  Millions$ 158.125  Millions
Inmed Pharmaceuticals Inc  14.57 $ 4.284  Millions$ 0.294  Millions
Biofrontera Inc   14.26 $ 61.432  Millions$ 4.308  Millions
Valion Bio Inc   14.02 $ 0.957  Millions$ 0.068  Millions
Mannkind Corporation  14.00 $ 267.200  Millions$ 19.086  Millions
Qhslab Inc   13.69 $ 1.821  Millions$ 0.133  Millions
Pluri Inc   13.36 $ 0.598  Millions$ 0.045  Millions
Dih Holding Us Inc   13.13 $ 116.794  Millions$ 8.898  Millions
Patterson Companies Inc   13.07 $ 6,555.862  Millions$ 501.549  Millions
Chemed Corporation  12.84 $ 2,377.206  Millions$ 185.072  Millions
International Stem Cell Corporation  12.65 $ 8.528  Millions$ 0.674  Millions
Nrc Health  12.61 $ 144.154  Millions$ 11.436  Millions
Poseida Therapeutics Inc   12.52 $ 150.858  Millions$ 12.053  Millions
Petvivo Holdings Inc   12.46 $ 0.969  Millions$ 0.078  Millions

Date modified: 2026-08-29T17:41:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.